Navid Malik
CIK: 0001629113
Recent activity
The filings on record name Navid Malik as Director of Northwest Biotherapeutics Inc. (NWBO).
Among the 3 most recent transactions on file, the largest reported open-market sale (Form 4 code S) is $241,605 in NWBO, dated Nov 17, 2023.
The most recent transaction on file, dated Nov 17, 2023, was reported in a Form 4 filed Dec 1, 2023, 14 days after the transaction date.
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NORTHWEST BIOTHERAPEUTICS INC
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Nov 17, 2023NWBO
NORTHWEST BIOTHERAPEUTICS INC
Sale(S)Direct150K shares at avg. $0.82$123K - Nov 17, 2023NWBO
NORTHWEST BIOTHERAPEUTICS INC
Sale(S)Direct295K shares at avg. $0.82$242K - Nov 16, 2023NWBO
NORTHWEST BIOTHERAPEUTICS INC
Sale(S)Direct125K shares at avg. $0.83$104K
1-3 of 3 transactions
Navid Malik files insider reports with the SEC as Director of Northwest Biotherapeutics Inc. (NWBO). Signal8 holds 3 reported Form 4/5 transactions by Navid Malik since Sep 2024. The most recent reported transaction is a sale (Form 4 code S) in NWBO, dated Nov 17, 2023.
About Navid Malik
Navid Malik (SEC CIK 0001629113) files insider reports with the SEC as Director of NORTHWEST BIOTHERAPEUTICS INC (NWBO).
Signal8 holds 1 ownership filing by Navid Malik, a Form 4, filed on Dec 1, 2023. Those filings report 3 transactions, from Nov 16, 2023 to Nov 17, 2023. Signal8's Form 4 history starts in Sep 2024.
The business address on Navid Malik's filings is in BETHESDA, MD.
Recent filings by Navid Malik
Other insiders filing for NORTHWEST BIOTHERAPEUTICS INC (NWBO)
- Alton L. Boynton, CHIEF SCIENTIFIC OFFICER